Effect of Repaglinide and Metformin Combination Therapy Compare With Repaglinide Monotherapy in Type 2 Diabetes Mellitus Treatment
碩士 === 長榮大學 === 醫學研究所 === 106 === Purpose: According to the demographics from Taiwan National Health Insurance Administration, Ministry of Health and Welfare, there are approximately 138 million diagnosed diabetes people in Taiwan. To control hyperglycemia well can decrease renal, ocular, and neural...
Main Authors: | Yi-Chiao Su, 蘇鉯喬 |
---|---|
Other Authors: | 陳宏一 |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/pq5j3v |
Similar Items
-
Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
by: J. Ma, et al.
Published: (2014-01-01) -
Fixed combination of repaglinide and metformin in the management of type 2 diabetes
by: Robert Moses
Published: (2009-06-01) -
Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats
by: Bonaventure Chukwunonso Obi, et al.
Published: (2016-01-01) -
Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes
by: John W. Richard, et al.
Published: (2011-01-01) -
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Moses R
Published: (2010-05-01)